The Blue Cross Blue Shield Association and 18 independent and locally-operated BCBS companies are partnering with Civica Rx to lower the cost of generic prescription drugs.

The 18 BCBS companies will provide $55 million to help create a Civica subsidiary, according to the BCBS Association. As a result of the partnership, Civica will produce certain generics taken outside the hospital setting.

The specific generics to be manufactured are still to be determined, but will treat a range of health conditions.

Read more at Healthcare Finance.